Infusystem Hldgs, Inc. (INFU) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
InfuSystem Reports First Quarter 2022 Financial Results
May 5, 2022 6:35 AM EDTSigned 3-year Master Service Agreement with Leading Global Medical Technology and Diagnostic Company Estimated Potential Annual Revenue of $10 Million to $12 Million
Revenue Growth of 9% - Driven by 18% Growth in DME and 5% in ITS
Strong Operating Cash Flow Growth of 54%
Repurchased Approximately $4 Million of Common Stock During the First Quarter under the $20 Million Stock Repurchase Program
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)-- InfuSystem Holdings, Inc. (NYSE American: INFU), (InfuSystem or the Company), a leading national... More
